was successfully added to your cart.
Professionals Track

Breakout Session 2: TBA B

By May 21, 2017 No Comments

TIME: 10:00am-11:30am
DATE: Saturday, October 14
ROOM: Hughes
SPEAKER: Kelly Roman, Co-Founder, Fisher Wallace Labs

There are a wide range of games in different genres on the internet. So, if you want to choose the right game, you should read the review or look through the comparison chart. Most of the websites offer not only friendly-used mobile versions but around-the-clock support without breaks and the days off. Also, you will not surprise anyone with possibility to play online casino free or for real money. I can't help but recommend you swanky casino gra fruit with plenty of games. It is just a treasure for those who love gaming. You will have a great opportunity to have a rest, to or to relieve stress without wasting time and money for traveling to Las Vegas. Don't forget to compare this site with your personal inquiries and wishes.

A New Treatment Option for Bipolar Depression May Improve Outcomes for Eating Disorder Patients

Code S11 :: Seminar Session :: 1.50 CE hours

Session Description

A recent NIH funded study determined that 68% of women with diagnosed eating disorders also suffer from co-morbid bipolar disorder. This presentation is designed to introduce researchers, clinicians and patients to FDA-Cleared, wearable neurostimulation that is used today to treat bipolar depression; discuss the reasons why the technology is relevant to eating disorder patients; take a deep dive into recent published research that demonstrates the tech’s safety and effectiveness in treating bipolar depression.

Learning Objectives

  • Describe medical grade wearable neurostimulation.
  • Discuss observational knowledge of the technology’s use by patients.
  • Describe how the technology may be deployed in the treatment of eating disorder patients who are suffering from mood and sleep disroders, and/or bipolar disorder.

About the Presenter

Kelly Roman, Co-Founder, Fisher Wallace Labs
Kelly co-founded Fisher Wallace Labs, a 10-year-old medical device company, where he leads product development, regulatory affairs, marketing, VR strategy. Prior to co-founding Fisher Wallace Labs, Kelly served as an executive at a venture backed software startup, Nielsen Media, and the scientific journal Nature. Kelly is known in the medical device industry as pioneering the commercialization of medical grade, wearable neurostimulation.